Wegovy 7.2 mg Prefilled Pen

Wegovy 7.2 mg Prefilled Pen

Wegovy 7.2 mg contains semaglutide, a GLP-1 receptor agonist used as part of a comprehensive weight-management programme alongside a reduced-calorie diet and increased physical activity.

The 7.2 mg strength is a higher maintenance dose for certain eligible adults who have been receiving Wegovy 2.4 mg and whose healthcare professional considers further dose escalation appropriate. It should not be used as an initial dose.

What is Wegovy 7.2 mg?

Wegovy 7.2 mg is supplied as a prefilled injection pen containing semaglutide. It is administered once weekly by subcutaneous injection according to the prescribing instructions.

The 7.2 mg dose is intended for specific eligible adults after treatment with the 2.4 mg dose. Treatment decisions should always be made by an appropriately qualified healthcare professional.

Wegovy 7.2 mg Dose Information

The standard Wegovy treatment pathway begins at a low dose and increases gradually. For adults who may be suitable for the higher maintenance dose, the UK prescribing information specifies that the dose can be increased from 2.4 mg to 7.2 mg after at least four weeks on 2.4 mg, where clinically appropriate.

Do not increase to 7.2 mg without specific medical advice.

How Does Wegovy Work?

Semaglutide acts on GLP-1 receptors involved in appetite regulation. It can affect feelings of hunger and fullness and may help reduce food intake when used alongside dietary and physical-activity measures.

Who May Use Wegovy 7.2 mg?

The 7.2 mg dose is not intended for everyone using Wegovy. A healthcare professional should determine whether a patient is suitable for this higher maintenance dose based on the current prescribing information, treatment response, tolerability and individual circumstances.

Important Safety Information

• Wegovy is a prescription-only medicine in the UK.
• Wegovy 7.2 mg should only be used when specifically prescribed or recommended by an appropriate healthcare professional.
• Do not use 7.2 mg as a starting dose.
• Do not combine Wegovy with another semaglutide-containing medicine or another GLP-1 receptor agonist unless specifically instructed by a healthcare professional.
• Gastrointestinal adverse effects such as nausea, vomiting, diarrhoea and constipation can occur.
• Seek urgent medical advice if you experience severe and persistent abdominal pain.
• Tell your healthcare professional about all medicines you take and any relevant medical conditions.
• Wegovy should not be used during pregnancy.

Product Information

• Active ingredient: Semaglutide
• Strength: 7.2 mg per dose
• Administration: Subcutaneous injection
• Frequency: Once weekly
• Indication: Weight management in eligible patients
• Legal category: Prescription-only medicine

Related Wegovy Products

If you are reviewing the Wegovy dose range, visit our Wegovy 2.4 mg Prefilled Pen page for information about the standard 2.4 mg maintenance strength.

You can also explore our Wegovy Products category and Weight Management Guide for related information.

Official UK Information

For the most up-to-date prescribing information, consult the official Wegovy 7.2 mg Summary of Product Characteristics and Patient Information Leaflet on the UK electronic Medicines Compendium.

Frequently Asked Questions

What is Wegovy 7.2 mg?

Wegovy 7.2 mg is a higher-strength semaglutide injection used as a maintenance dose for certain eligible adults who have previously received Wegovy 2.4 mg.

Is Wegovy 7.2 mg a prescription medicine?

Yes. Wegovy is a prescription-only medicine in the UK.

Can I start Wegovy at 7.2 mg?

No. The 7.2 mg strength is not a starting dose. It may be considered after appropriate treatment with lower Wegovy doses and specifically according to the prescribing information.

How often is Wegovy 7.2 mg administered?

Wegovy is administered once weekly according to the prescribed treatment plan.

Who should decide whether I need 7.2 mg?

Your healthcare professional should determine whether the 7.2 mg dose is appropriate for you.

Where can I find official information?

The UK electronic Medicines Compendium provides the official prescribing and patient information for Wegovy 7.2 mg.